MLICM
AKTS

Metropolitan Life Insurance Company (MetLife)’s Akoustis Technologies Inc AKTS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,629
Closed -$11.5K – 2460
2023
Q2 		$11.5K Hold
3,629
– – ﹤0.01% 2229
2023
Q1 		$11.2K Buy
3,629
+281
+8% +$980 ﹤0.01% 2113
2022
Q4 		$9.44K Buy
3,348
+70
+2% +$220 ﹤0.01% 2298
2022
Q3 		$9.74K Buy
3,278
+2,843
+654% +$11.5K ﹤0.01% 2286
2022
Q2 		$1.61K Sell
435
-2,656
-86% -$11.8K ﹤0.01% 2364
2022
Q1 		$20.1K Sell
3,091
-7,057
-70% -$42K ﹤0.01% 2093
2021
Q4 		$67.8K Sell
10,148
-64
-0.6% -$478 ﹤0.01% 2653
2021
Q3 		$99.1K Buy
10,212
+717
+8% +$6.87K ﹤0.01% 2520
2021
Q2 		$102K Buy
9,495
+1,052
+12% +$11.1K ﹤0.01% 2586
2021
Q1 		$113K Sell
8,443
-1,142
-12% -$16.6K ﹤0.01% 2371
2020
Q4 		$117K Buy
9,585
+6,007
+168% +$52.7K ﹤0.01% 2273
2020
Q3 		$29.2K Sell
3,578
-6,098
-63% -$49.3K ﹤0.01% 2512
2020
Q2 		$80.2K Buy
9,676
+7,433
+331% +$57.4K ﹤0.01% 2377
2020
Q1 		$12K Buy
+2,243
New +$15.7K ﹤0.01% 2482

Other funds holding AKTS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
HIM
Herald Investment Management London, United Kingdom $737M AUM 158.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AKTS Position: Q3 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Akoustis Technologies Inc (AKTS) in Q3 2023, closing a stake of 3,629 shares — an estimated $11.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AKTS in Q1 2020 and held it in 14 quarters. The position peaked at $117K in Q4 2020. 120 funds tracked by Wall St. Rank hold AKTS as of Q3 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Akoustis Technologies Inc position as of Q3 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,629 Akoustis Technologies Inc shares in Q3 2023, an estimated $11.5K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Akoustis Technologies Inc in Q1 2020 and held it in 14 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Akoustis Technologies Inc position peaked at $117K in Q4 2020.
  • 120 funds tracked by Wall St. Rank held Akoustis Technologies Inc as of Q3 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2023, filed 14 Nov 2023.